Hubei Guangji Pharmaceutical Co (SZSE:000952) Accounts Payable & Accrued Expense : ¥300.1 Mil (As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co Accounts Payable & Accrued Expense?

Hubei Guangji Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (¥301.3 Mil) to Dec. 2024 (¥235.8 Mil) but then increased from Dec. 2024 (¥235.8 Mil) to Mar. 2025 (¥300.1 Mil).

Hubei Guangji Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (¥291.0 Mil) to Dec. 2023 (¥252.1 Mil) and declined from Dec. 2023 (¥252.1 Mil) to Dec. 2024 (¥235.8 Mil).

Hubei Guangji Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Hubei Guangji Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

218.53

190.54

290.99

252.07

235.79

Hubei Guangji Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															231.21	226.48	301.25	235.79	300.07

Hubei Guangji Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hubei Guangji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030

Website

http://www.guangjipharm.com

Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.

Executives

Zou Guang Ming	Independent director
Guo Shao Zhi	Executives
Zhang Bin	Director
Guo Wen Chao	Supervisors
Sun Zhen Hua	Director
Liao Qing Jiang	Director
Wang Xin	Directors, executives
Hu Feng Lei	Supervisors
Ruan Zhong Yi	Executives
Zhang Ping	Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines